Akima Harada

Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction

Masaru Ishida, Shigeru Miyagawa, Atsuhiro Saito et al. · Transplantation · 2018 · 104 citations · Full text

Medicine, Cardiology, Cell Therapy +16

Development of <i>In Vitro</i> Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells

Maki Takeda, Shigeru Miyagawa, Satsuki Fukushima et al. · Tissue Engineering Part C Methods · 2017 · 103 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue

Hiroko Iseoka, Shigeru Miyagawa, Satsuki Fukushima et al. · Tissue Engineering Part A · 2017 · 76 citations · Full text

Engineering, Bioengineering, Cardiology +17

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy

Nagako Sougawa, Shigeru Miyagawa, Satsuki Fukushima et al. · Scientific Reports · 2018 · 57 citations · Full text

Medicine, Cardiology, Apoptosis +13

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application

Emiko Ito, Shigeru Miyagawa, Maki Takeda et al. · Scientific Reports · 2019 · 54 citations · Full text

Life Sciences, Cardiology, Cell Biology +15